JRC news and updates

What are the most promising current and emerging technologies when the next airborne disease hits?

Analysis of patented biotechnology inventions worldwide shows how the EU positions itself compared to the US and China.

Discover what it is like to be a scientist where research and policy combine.

The number of people living with a cancer diagnosis is increasing in the EU, partly due to an ageing population.

Exacerbated by an ageing population, the burden of cancer is increasing, with the number of new cases reaching 2.74 million in 2022.

How the JRC contributed to developing the EU common list of COVID-19 antigen tests that has allowed millions to safely travel during the pandemic. A great example of how the JRC’s science benefits everyone in Europe!

Tracing COVID-19 in clinical swabs and wastewater: our methods and reference materials.

COVID-19 caused disruptions in the economic, education and health care sectors, for example. In this article, we focus on the challenges posed to the oncology community.

The Commission’s European Cancer Inequalities Registry is helping policy makers and researchers to address cancer inequalities and disparities.